| Literature DB >> 34262271 |
Qinxin Liu1, Hongxia Duan1, Anbei Lian1, Min Zhuang1,2, Xianli Zhao1, Xiaodan Liu1,3.
Abstract
Introduction: Diaphragm dysfunction is a significant extrapulmonary effect in chronic obstructive pulmonary disease (COPD), which is manifested by changes in diaphragm structure and reduced diaphragm strength. Acupuncture is a traditional rehabilitation technique in China, which has been used in rehabilitation for COPD. But whether acupuncture can improve the diaphragm function of COPD patients remains to be verified. Objective: The objective of this study was to evaluate the rehabilitation effects of acupuncture on diaphragm dysfunction in patients with COPD.Entities:
Keywords: acupuncture; chronic obstructive pulmonary disease; diaphragm; dysfunction; rehabilitation effect
Year: 2021 PMID: 34262271 PMCID: PMC8275099 DOI: 10.2147/COPD.S313439
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
The Physiotherapy Evidence Database Scale
| 1. Eligibility criteria were specified | No | Yes |
| 2. Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order in which treatments were received) | No | Yes |
| 3. Allocation was concealed | No | Yes |
| 4. The groups were similar at baseline regarding the most important prognostic indicators | No | Yes |
| 5. There was blinding of all subjects | No | Yes |
| 6. There was blinding of all therapists who administered the therapy | No | Yes |
| 7. There was blinding of all assessors who measured at least one key outcome | No | Yes |
| 8. Measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups | No | Yes |
| 9. All subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome was analysed by “intention to treat” | No | Yes |
| 10. The results of between-group statistical comparisons are reported for at least one key outcome | No | Yes |
| 11. The study provides both point measures and measures of variability for at least one key outcome | No | Yes |
Figure 1Systematic search flowchart.
Characteristics of Studies Included in This Review
| First Author(Year) | Patients | Intervention | Outcome | |||
|---|---|---|---|---|---|---|
| Observation Group | Control Group | Diaphragm Function | Pulmonary Function | Arterial Blood Gases | ||
| Deng YQ (2019) | GOLD II–III, stable COPD | Warming acupuncture+ Standard therapy+ Rehabilitation training (n=45) | Standard therapy+ Rehabilitation training (n=45) | MIP# | FVC# | PaO2# |
| Suzuki M (2012) | GOLD II–IV, stable COPD | Filiform needle acupuncture+ Standard therapy (n=34) | Sham acupuncture+ Standard therapy (n=34) | MIP# | FVC# | PaO2† |
| Xu YG (2008) | GOLD III, stable COPD | Big-needle acupuncture + Standard therapy (n=20) | Filiform needle group: Filiform needle acupuncture+ Standard therapy (n=20) | MIP*# | / | / |
| Blank group: Standard therapy (n=20) | ||||||
| Lin LJ (2015) | Stable COPD | Warming acupuncture+ Chinese materia medica+ Standard therapy (n=40) | Standard therapy (n=40) | MIP*# | FEV1*# | / |
| Wu LL (2019) | GOLD II–IV | Filiform needle acupuncture+ Shenmai injection + Standard therapy (n=46) | Standard therapy (n=45) | DE*# | / | PaO2*# |
| Guan W (2016) | AECOPD | Abdominal acupuncture+ Standard therapy (n=33) | Standard therapy (n=34) | ARMM | FEV1/FVC**## | PaO2**## |
| Wang Y (2020) | AECOPD | Abdominal acupuncture+ Standard therapy (n=50) | Standard therapy (n=50) | ARMM*# | FEV1/FVC** | PaO2**## |
| Wang JY (2015) | AECOPD | Filiform needle acupuncture + Standard therapy (n=32) | Standard therapy (n=31) | MIP**## | FVC## | PaO2**# |
| Cheng YY (2017) | AECOPD | Abdominal acupuncture+ Standard therapy (n=34) | Standard therapy (n=34) | ARMM*# | VC%* | PaO2* |
Notes: /, not reported; *Compare the data between post-intervention and pre-intervention in the observation group, P value < 0.05; #Compare the post-intervention data between observation group and control group, P value < 0.05; **Compare the data between post-intervention and pre-intervention in the observation group, P value < 0.01; ##Compare the post-intervention data between observation group and control group, P value < 0.01; †Compare the changes from baseline to post-intervention data between the observation group and the control group, P value < 0.05.
Abbreviations: ARMM, the scale for accessory respiratory muscle mobilization; DE, diaphragmatic excursion; DTF, diaphragm thickening fraction; DE/TPIAdia, diaphragm contraction speed; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; FEV1%pred, forced expiratory volume in one second/prediction; FEV1/FVC%, FEV1/FVC ratio; MIP, maximal inspiratory pressure; MVV, maximal voluntary ventilation; PaO2, arterial partial pressure of oxygen; PaCO2, arterial partial pressure of carbon dioxide; D-RSBI, diaphragmatic-rapid shallow breathing index; VC, vital capacity.
PEDro Rating for Trials Included
| Trials | Eligibility Criteria | Random Allocation | Concealed Allocation | Baseline Similar | Blinding (Subject) | Blinding (Therapist) | Blinding (Assessor) | Measures >85% | ITT | Group Comparison | Point Measures | PEDro Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wang JY | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Deng YQ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| GuanW | Yes | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
| Suzuki M | Yes | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 8 |
| WangY | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Xu YG | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Lin LJ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Wu LL | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Cheng YY | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Note: 1, PEDro criteria met; 0, PEDro criteria not met.
Abbreviation: ITT, intention-to-treat analysis.
Characteristics of Acupuncture Schemes of Included Study for Diaphragm Dysfunction in COPD
| First Author(Year) | Acupoints | Type of Acupuncture | Stimulation Time | Acupuncture Frequency | Treatment Duration |
|---|---|---|---|---|---|
| Deng YQ (2019) | BL13, BL23, BL12, BL43, CV17, EX-B1, ST36, LU7, LU5, ST40, SP10 | Warming acupuncture | 3–4 Zhuang | 5 times a week | / |
| Suzuki M (2012) | LU1, LU9, ST32, CV4, CV12, ST36, KI3, SI4, BL13, BL20, BL23 | Filiform needle acupuncture | 50 min | Once a week | 12 weeks |
| Xu YG (2008) | CV17 | Big-needle acupuncture | 4 h | 5 times a week | 4 weeks |
| Filiform needle acupuncture | 30 min | ||||
| Lin LJ (2015) | ST36, CV6, BL13, BL20, BL23, EX-B1 | Warming acupuncture | 5 Zhuang | Once a day | 8 weeks |
| Wu LL (2019) | BL21, BL20, BL23, BL13, LU9, KI3, ST36 | Filiform needle acupuncture | 30 min | Once pre 12 h | / |
| Guan W (2016) | CV12, CV10, CV6, CV4, ST24, ST25, SP15, GB26 | Abdominal acupuncture | 30 min | Once a day for the first 3 days; once every other day for the next 11days | 14 days |
| Wang Y (2020) | CV12, CV10, CV4, ST25, GB26, SP15 | Abdominal acupuncture | 18 min | / | 2 weeks |
| Wang JY (2015) | ST36, ST40, SP6, SP15, CV12, CV13, CV6, CV4, LU9, LU5, LU6, EX-B1 | Filiform needle acupuncture | 30 min | Once a day | 40 days |
| Cheng YY (2017) | CV12, CV10, CV6, CV4, ST24, ST25, SP15, GB26 | Abdominal acupuncture | 30 min | Once a day for the first 3 days; once every other day for the next 11days | 7days |
Note: /, not reported.
Figure 2High-frequency selected acupoints.
Figure 3Mechanism of acupuncture on diaphragm dysfunction in COPD.